부갑상선 호르몬 시장 보고서(2026년)

Parathyroid hormone is a substance secreted by the parathyroid gland that helps regulate the storage and use of calcium in the body. Elevated levels of parathyroid hormone can lead to increased blood calcium levels and may indicate the presence of a disease. It is also referred to as PTH, parathyrin, and parathormone.

The primary product types in the parathyroid hormone category include recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, which imitates the action of natural parathyroid hormone, is utilized in the treatment of osteoporosis. The various conditions addressed include hypocalcemia and hypoparathyroidism, and these products are used across multiple settings such as hospitals, clinics, and others.

Tariffs have impacted the parathyroid hormone market by increasing the cost of imported recombinant hormones, analogues, and related medical devices. Hospital and clinic segments in regions like North America and Europe, which depend on imports, are most affected. This has led to higher treatment costs and supply chain challenges. However, tariffs have also promoted local manufacturing, encouraged innovation in hormone therapies, and supported the development of cost-optimized solutions.

The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides parathyroid hormone market statistics, including parathyroid hormone industry global market size, regional shares, competitors with a parathyroid hormone market share, detailed parathyroid hormone market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. This parathyroid hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The parathyroid hormone market size has grown rapidly in recent years. It will grow from $2.51 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to limited availability of recombinant parathyroid hormone, low disease awareness among patients, reliance on conventional vitamin d therapy, growing hospital and clinic infrastructure, increasing post-surgical parathyroid complications.

The parathyroid hormone market size is expected to see rapid growth in the next few years. It will grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to development of advanced parathyroid hormone analogues, rising adoption of personalized medicine approaches, expansion of hospital and specialty clinics, integration of digital patient monitoring tools, increasing government and healthcare initiatives for hypocalcemia and hypoparathyroidism. Major trends in the forecast period include rising incidence of hypocalcemia and hypoparathyroidism, increasing use of recombinant parathyroid hormone therapies, growth in parathyroid hormone analogues for personalized treatment, expansion of hospital and clinic-based parathyroid care programs, focus on post-surgical management and vitamin d supplementation.

The growing geriatric population is expected to drive the expansion of the parathyroid hormone market in the coming years. The geriatric population includes older adults, generally aged 65 years and above, who often face age-related health conditions and require specialized medical care and support. This demographic trend is largely the result of longer life expectancy, improvements in healthcare, and declining birth rates, which together have increased the proportion of elderly individuals worldwide. Parathyroid hormone plays an important role for older adults by regulating calcium balance and bone metabolism, thereby helping reduce the risk of osteoporosis and fractures, conditions commonly seen in the aging population. For example, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Additionally, this age group's share of the total population is expected to grow from 17% to 23% over the same period. As a result, the expanding geriatric population is contributing significantly to the growth of the parathyroid hormone market.

Leading companies in the parathyroid hormone market are concentrating on the development of biosimilars of parathyroid-based therapies, including prodrugs of parathyroid hormone (PTH), to improve treatment availability and effectiveness. A parathyroid hormone prodrug is an inactive substance that converts into active PTH after administration, allowing for sustained release and consistent therapeutic effects to support calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, announced that the Food & Drug Administration (FDA) had approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug provides continuous PTH exposure and is designed to benefit approximately 70,000 to 90,000 patients in the United States. The manufacturer, Ascendis Pharma, also offers patient support through its Ascendis Signature Access Program (A.S.A.P.), although patients are required to regularly monitor serum calcium levels to manage the risk of hypercalcemia or hypocalcemia.

In November 2023, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, entered into a strategic partnership with Teijin Limited in Japan to support the development and commercialization of innovative therapies. This collaboration is intended to broaden access to Ascendis Pharma's pipeline products, improve patient care in Japan, and promote innovation and growth within the rare disease and endocrine therapeutics market. Teijin Limited is a Japan-based healthcare and pharmaceutical company dedicated to providing advanced therapies and solutions to address unmet medical needs.

Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Hormone Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses parathyroid hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Disease Type: Hypocalcemia; Hypoparathyroidism
• 2) By Product Type: Recombinant Parathyroid Hormone; Parathyroid Hormone Analogues
• 3) By End-User: Hospitals; Clinics; Other End-Users
• Subsegments:
• 1) By Hypocalcemia: Pseudohypoparathyroidism; Vitamin D Deficiency
• 2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism; Idiopathic Hypoparathyroidism
• Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Ascendis Pharma; Entera Bio Ltd.; Extend Biosciences Inc.; Gedeon Richter Plc.; Abbott Laboratories; Amgen Inc.; Merck & Co. Inc.; Novartis AG; F. Hoffmann-La Roche AG; Teva Pharmaceutical Industries Ltd.; Alcon Laboratories Inc.; Bayer Healthcare; AstraZeneca PLC; Biocon; Dr. Reddy's Laboratories; Glenmark Pharmaceuticals; Jubilant Life Sciences; Lupin Limited; Sun Pharmaceutical Industries; Torrent Pharmaceuticals; Wockhardt; Cipla Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Parathyroid Hormone Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Parathyroid Hormone Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Parathyroid Hormone Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Parathyroid Hormone Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Incidence Of Hypocalcemia And Hypoparathyroidism
  • 4.2.2 Increasing Use Of Recombinant Parathyroid Hormone Therapies
  • 4.2.3 Growth In Parathyroid Hormone Analogues For Personalized Treatment
  • 4.2.4 Expansion Of Hospital And Clinic-Based Parathyroid Care Programs
  • 4.2.5 Focus On Post-Surgical Management And Vitamin D Supplementation

5. Parathyroid Hormone Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Specialty Endocrinology Centers
• 5.4 Diagnostic Laboratories
• 5.5 Home Healthcare Providers

6. Parathyroid Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Parathyroid Hormone Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Parathyroid Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Parathyroid Hormone Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Parathyroid Hormone Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Parathyroid Hormone Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Parathyroid Hormone Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Parathyroid Hormone Market Segmentation

• 9.1. Global Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hypocalcemia, Hypoparathyroidism
• 9.2. Global Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
• 9.3. Global Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Other End-Users
• 9.4. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypocalcemia, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pseudohypoparathyroidism, Vitamin D Deficiency
• 9.5. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypoparathyroidism, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

10. Parathyroid Hormone Market Regional And Country Analysis

• 10.1. Global Parathyroid Hormone Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Parathyroid Hormone Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Parathyroid Hormone Market

• 11.1. Asia-Pacific Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Parathyroid Hormone Market

• 12.1. China Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Parathyroid Hormone Market

• 13.1. India Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Parathyroid Hormone Market

• 14.1. Japan Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Parathyroid Hormone Market

• 15.1. Australia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Parathyroid Hormone Market

• 16.1. Indonesia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Parathyroid Hormone Market

• 17.1. South Korea Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Parathyroid Hormone Market

• 18.1. Taiwan Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Parathyroid Hormone Market

• 19.1. South East Asia Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Parathyroid Hormone Market

• 20.1. Western Europe Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Parathyroid Hormone Market

• 21.1. UK Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Parathyroid Hormone Market

• 22.1. Germany Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Parathyroid Hormone Market

• 23.1. France Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Parathyroid Hormone Market

• 24.1. Italy Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Parathyroid Hormone Market

• 25.1. Spain Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Parathyroid Hormone Market

• 26.1. Eastern Europe Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Parathyroid Hormone Market

• 27.1. Russia Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Parathyroid Hormone Market

• 28.1. North America Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Parathyroid Hormone Market

• 29.1. USA Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Parathyroid Hormone Market

• 30.1. Canada Parathyroid Hormone Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Parathyroid Hormone Market

• 31.1. South America Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Parathyroid Hormone Market

• 32.1. Brazil Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Parathyroid Hormone Market

• 33.1. Middle East Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Parathyroid Hormone Market

• 34.1. Africa Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Parathyroid Hormone Market, Segmentation By Disease Type, Segmentation By Product Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Parathyroid Hormone Market Regulatory and Investment Landscape

36. Parathyroid Hormone Market Competitive Landscape And Company Profiles

• 36.1. Parathyroid Hormone Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Parathyroid Hormone Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Parathyroid Hormone Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Radius Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Ascendis Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Entera Bio Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Parathyroid Hormone Market Other Major And Innovative Companies

• Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences

38. Global Parathyroid Hormone Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Parathyroid Hormone Market

40. Parathyroid Hormone Market High Potential Countries, Segments and Strategies

• 40.1 Parathyroid Hormone Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Parathyroid Hormone Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Parathyroid Hormone Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer